Fairfield Financial Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $309K | Sell |
|
|||||
|
2025
Q3 | $635K | Sell |
|
|||||
|
2025
Q2 | $2.1M | Sell |
|
|||||
|
2025
Q1 | $2.9M | Sell |
|
|||||
|
2024
Q4 | $3.77M | Sell |
|
|||||
|
2024
Q3 | $6.2M | Buy |
|
|||||
|
2024
Q2 | $6.92M | Buy |
|
|||||
|
2023
Q4 | $3.9M | Buy |
|
|||||
|
2023
Q3 | $2.77M | Buy |
|
|||||
|
2023
Q2 | $1.85M | Buy |
|
|||||
|
2023
Q1 | $1.22M | Buy |
|
|||||
|
2022
Q4 | $882K | Sell |
|
|||||
|
2022
Q3 | $689K | Buy |
|
|||||
|
2022
Q2 | $673K | Buy |
|
|||||
|
2022
Q1 | $389K | Buy |
|